Medpace Holdings MEDP
NASDAQ MEDP
$615.11 -1.33 (-0.22%)
As of: Sep 17, 2026 · 3:59 PM EDT

Medpace Holdings (MEDP) Non Operating Income (2015 - 2026)

Medpace Holdings' (MEDP) quarterly Non Operating Income came in at $4.8 million in Q2 2026, up 369.28% on a YoY basis from $1.0 million in Q2 2025, and down 20.52% quarter-over-quarter from $6.1 million in Q1 2026.

Analysis

Medpace Holdings (MEDP) Non Operating Income (2015 - 2026) Analysis & Trends

Medpace Holdings (MEDP) has reported Non Operating Income for 12 consecutive years, with $4.8 million the latest figure, recorded in Q2 2026.

  • For the quarter ending Q2 2026, Non Operating Income rose 369.28% year-over-year to $4.8 million; the trailing twelve-month figure through Jun 2026 stood at $15.5 million (down 13.09% YoY), and the FY2025 full-year result was $7.4 million, down 74.38% from the prior year.
  • Non Operating Income eased to $4.8 million in Q2 2026 per MEDP's latest filing, from $6.1 million in the prior quarter.
  • Across five years, Non Operating Income topped out at $8.7 million in Q1 2024 and bottomed at -$2.8 million in Q4 2022.
  • Historically, Non Operating Income has averaged $2.8 million across 5 years, with a median of $3.5 million in 2023.
  • The sharpest annual moves came in 2022 and 2024: Non Operating Income slumped 361.35% in 2022, then jumped 5107.47% in 2024.
  • Over 5 years, Non Operating Income stood at -$2.8 million in 2022, then jumped by 221.57% to $3.4 million in 2023, then soared by 151.08% to $8.5 million in 2024, then tumbled by 58.09% to $3.6 million in 2025, then surged by 35.77% to $4.8 million in 2026.
  • According to Business Quant data, Non Operating Income over the past three periods registered $4.8 million, $6.1 million, and $3.6 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non Op. Inc. (Qtr)
1 Iqvia Holdings 44.72 Bn 42.64 Bn 1.44 Bn -
2 Medpace Holdings 17.37 Bn 16.87 Bn 201.64 Mn 4.84 Mn
3 Icon 13.65 Bn 12.72 Bn 479.29 Mn -
4 Charles River Laboratories International 13.13 Bn 12.94 Bn 452.07 Mn -
5 Fortrea Holdings 1.89 Bn 1.72 Bn 139.20 Mn -
6 Evotec SE 574.75 Mn 148.87 Mn - -
7 Ginkgo Bioworks Holdings 439.63 Mn 355.09 Mn 18.44 Mn -
8 Champions Oncology 69.43 Mn 65.03 Mn 7.70 Mn -
9 MindWalk Holdings 51.76 Mn 46.29 Mn 1.61 Mn -
10 VivoSim Labs 1.37 Mn 1.37 Mn - 1.42 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 4.84 Mn
Mar 31, 2026 6.09 Mn
Dec 31, 2025 3.56 Mn
Sep 30, 2025 1.03 Mn
Jun 30, 2025 -1.80 Mn
Mar 31, 2025 4.65 Mn
Dec 31, 2024 8.50 Mn
Sep 30, 2024 6.50 Mn
Jun 30, 2024 5.33 Mn
Mar 31, 2024 8.71 Mn
Dec 31, 2023 3.39 Mn
Sep 30, 2023 -1.71 Mn
Jun 30, 2023 -2.65 Mn
Mar 31, 2023 -174,000.00
Dec 31, 2022 -2.79 Mn
Sep 30, 2022 4.07 Mn
Jun 30, 2022 1.76 Mn
Mar 31, 2022 1.12 Mn
Dec 31, 2021 1.07 Mn
Sep 30, 2021 1.02 Mn